Remove Drugs Remove Online Pharmacies Remove Pharmaceuticals
article thumbnail

The Domain Reform for Unlawful Drug Sellers Act is Big Pharma’s Bill

Policy Prescription

Mark Rubio (R-FL) and Amy Klobuchar (D-MN) , called the “Domain Reform for Unlawful Drug Sellers Act’’ or, for short, the ‘‘DRUGS Act,’’ could effectively end online access to safe and affordable imported medicines for Americans. But the FDA already has a program for tackling online opioid drug dealers.

article thumbnail

Mark Cuban’s Pharmacy Dreams Are Generic

Policy Prescription

Mark Cuban’s new online pharmacy venture – the Mark Cuban Cost Plus Drug Company (“Cost Plus Drug”) – will not help overcome the biggest obstacle to drug affordability in America, which is drug company monopolies on patented brand name prescription drugs. So, why do we need Cuban’s Cost Plus?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Manitoba Judge’s Opinion Reveals Different Side of the CanadaDrugs Case

Policy Prescription

A recent opinion from an appeals court in Manitoba, Canada sheds new and more favorable light about the CanadaDrugs-related wholesale drug importation case that was first covered a decade ago in the Wall Street Journal. for sales of mostly misbranded (but not counterfeit drugs) and two batches of counterfeit drugs. supply chain.

article thumbnail

How Pharma-Funded Groups Lie About Personal Drug Imports

Policy Prescription

For the past decade, I’ve written extensively about my view that pharma-funded organizations and initiatives are responsible for misleading Americans about the safety of buying more affordable prescription drugs over the Internet for import from Canada and other countries. Here’s one example and you can be the judge.

article thumbnail

DOJ Investigates $250 Million in U.S. Sales of Counterfeit Drugs Using Fake DSCSA Pedigrees

Policy Prescription

Department of Justice, according to Seeking Alpha , is investigating the sale and distribution of counterfeit drugs in the U.S. drug supply chain consisting of $250 million in counterfeit HIV drugs that were sold throughout the U.S. from licensed pharmacies to American patients.